Objective: Th e aim of this study is to evaluate the incidence and distribution of cervical lesions and compare characteristics such as parity and age of the women in Mardin province. Results: Th ere were 3.332 patients in total, whose smears showed no lesions in 3.125 patients. Th e mean age and number of parities of those patients were 37.34±11.25 and 4.78±3.28. Th ere were 207 smears showing any lesions in cervix; ASC-US, ASC-H, LSIL, HSIL, AGC, squamous cell carcinoma and endocervical adenocarcinoma in 151 (72.94%); 16 (7.72%); 20 (9.66%); 8 (3.86%); 10 (4.83%); 1 (0.48%) and 1 (0.48%) patient, respectively. Th e mean age and the parities of the patients were 37.63±10.77 years and 4,74±2,92. Although there was no diff erence between the control and lesion groups, the parity and the age of patients who had ≥4 births in both the control and lesion groups were significantly higher than the patients with parities <4 births (p=0.000). Th ere was no diff erence within the cervical lesion group comparing the ASC-US group with the total of the other lesions.
INTRODUCTION
Cervical cancer accounts for 15% of all cancers in women and is the second most common cancer aff ecting women worldwide. Almost 85% of these cases occur in low-income countries (1) .
It is well known that population-based cervical cancer screening using the Papanicolaou (Pap) test makes the early diagnosis of cervical cancer possible. Th e role of high risk Human Papilloma Virus (HPV) in the progression of cervical intraepithelial neoplasia to malignancy is well demonstrated. Th ere are also many other aetiological factors that might contribute to the development of cervical carcinoma. Th ese are high age and high parity, early age at fi rst sexual intercourse, having multiple sex partners and smoking (2). Cervical cancer is the ninth most common cancer among women in Turkey and ranks 13th among cancer related deaths. More than 50% of the 1.364 patients diagnosed with cervical cancer each year in Turkey die of the disease (3).
Although national screening programs have been initiated by the Ministry of Health, information about the incidence of cervical cancer by province does not exist. Th e aim of the present study was to evaluate the prevalence of cervical cytological abnormalities and the association with parity.
MATERIAL and METHODS
A total of 5.984 Pap smears were obtained from the women screened at Mardin Gynecology and Pediatric Diseases Hospital from May 2008 to February 2011. All cervicovaginal smears were conventional Pap smear samples evaluated by two diff erent pathologists at the Pathology unit according to the 2001 Bethesda system criteria. Th e Pap smear results were re-assessed and the information about parity was also accessed from the archives. Th ose where information about parity was not available were excluded from the study. Th us the study was eventually carried out with 3.332 patients. Th e records of all patients with a diagnosis of atypical squamous cells with undetermined signifi cance (ASC-US), atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (H-SIL) (ASC-H), atypical glandular cells (AGC), low-grade squamous intraepithelial lesion (L-SIL), squamous cell carcinoma or adenocarcinoma were reviewed for numbers of parity and patients' ages.
Statistical analysis was performed with the SPSS statistical soft ware for Windows, version 13.0 (SPSS Inc, Chicago, IL, USA). Continuous variables were expressed with mean±SD, median, maximum-minimum. Th e normality of data for continuous variables (age and parity) was checked using the Kolmogorov-Smirnov test before the statistical analysis was performed. Diff erences between groups were analyzed using the Student T-test for continuous variables. A P value of 0.05 was considered to be statistically signifi cant.
RESULTS
Th e total number of re-evaluated smears was 3.332. Th e medical records of all patients were reviewed for numbers of parity and age. Th ere were 3.125 smears which showed no lesions, accepted as the control group. Th e mean age of those patients was 37,34±11,25 (median: 36; min: 14, max: 82) years and the mean number of parities was 4.78±3.28 (median: 4; min: 0, max: 20). Th ere were 207 smears showing any lesion. Th e distribution of the diagnoses of the smears was listed as: ASC-US in 151 (72.94%); ASC-H in 16 (7.72%); L-SIL in 20 (9.66%); H-SILs in 8 (3.86%); AGC in 10 (4.83%). Th e prevalence of invasive cervical neoplasia was 0.06%. Th ere was squamous cell carcinoma in 1 patient (0.48%) and endocervical adenocarcinoma in 1 patient (0.48%). Th e mean age of the 207 patients was 37.63±10.77 (median: 37; min: 18, max: 78) years and mean number of parities was 4.74±2.92 (median: 4; min: 0, max: 17). Th ere were no diff erences between the control group and cervical lesion group by age and the number of parities (Table I ).
In the control group, there were 1,811 patients who had ≥4 births, and 1.314 patients who had <4 births. Th e mean age and parities of the patients who had ≥4 births were 41.86±10.64 (median: 41; min: 16, max: 82) years and 6.88±2.71 (median: 6; min: 4, max : 20) . Th e mean age and parities of the 1,314 patients who had <4 births were 31.10±8.83 (median: 29,5; min: 14, max: 79) years and 1.88±0.98 (median: 2; min: 0, max: 3). In the cervical lesion group, there were 128 patients who had ≥4 births, and 79 patients who had <4 births. Th e mean age and parities of the patients who had ≥4 births were 41.05±10.61 (median: 40; min: 21, max: 77) years and 6.39±2.49 (median: 6; min: 4, max: 17). Th e mean age and parities of the 79 patients who had <4 births were 32.09±8.55 (median: 31; min: 17, max: 60) years and 2.08±0.87 (median: 2; min: 0, max: 3). In both the control group and the cervical lesion group, the mean parity numbers and the ages of patients who had ≥4 births was signifi cantly higher than the patients who had <4 births (p=0.000; 0.000; 0.000 and 0.000, respectively) (Table  II) .
Th ere was no statistically signifi cant diff erence in the lesion group itself when comparing the ASC-US group with the total of the other lesions (LSIL, HSIL, ASC-H, AGC, SCC and adenocarcinoma) (Table III) . 
DISCUSSION
Th e incidence and mortality rates of cervical cancer have decreased dramatically in many European countries since the introduction of the Pap test in the early 1940s and the ensuing implementation of national screening programs. Despite false-negative rates between 6% and 50%, this test is still considered the most eff ective to detect precancerous lesions (4) . Th e 2001 Bethesda System for reporting cervical or vaginal cytologic diagnoses is an incremental change in the uniform terminology introduced in 1988 and revised in 1991 (5) . Th e existing screening programs have decreased the prevalence of cervical carcinoma, which used to be one of the leading causes of death among women. In Turkey, local health programs of Ministry of Health and an increased awareness in the community have lowered the prevalence of cervical carcinomas from the seventh cause of death for women in 1996 to the eighth in 2006 (6).
A variety of possible cofactors have been identifi ed with varying degrees of consistency that could act either before or aft er the development of in situ disease. Th ese include the followings: early age at fi rst sexual intercourse, which may refl ect particular vulnerability of the immature cervix to HPV-induced carcinogenesis, hormonal factors such as high parity and use of oral contraceptives, exposures to chemical agents in cigarette smoke, sexually transmitted agents (HPV and others), an immunocompromised state resulting from human immunodefi ciency virus (HIV) infection or immunosuppression for prevention of organ transplant rejection, and various measures of socioeconomic status, suggesting the presence of additional unrecognized cofactors associated with social class (7).
Cervical cancer also seems to be associated with continued multiple damages and injuries. Th is type of cancer is more frequent in women in low socioeconomic groups and is connected with engaging in fi rst coitus at early ages and having multiple sexual partners (8) . Th e population of Mardin province, the city center and related villages, is 744,606 (9) . It is a city in the south-east region and rates of parity are higher than other provinces which are located in western regions of Turkey. Considering the ages at fi rst between abnormal cervical cytology and having cervical erosion regardless of HPV infection (13) . We had been working in that hospital while we served our compulsory services and the Pathology unit consisted of only a cytology laboratory. Unfortunately, there were no opportunities to compare the diagnosis between the smears and biopsies.
Although there was no colposcope or HPV DNA testing in Mardin province, we had still written foot-notes about suggested colposcopic assessment for ASC-H, L-SIL, and H-SIL within the fi nal reports.
Parity was one of the earliest risk factors to be associated with cancer risk. Already in 1842, on the basis of death certifi cates in Verona, Italy, Rigoni-Stern observed that cancers of the uterus (which at that time chiefl y originated from the cervix) were more frequent in married women, who tended to be multiparous (15) . High parity was one of the risk factors for cervical cancer (16, 17) . In another study the risk increased markedly with increasing parity and was over four-fold in women with four or more births, compared with women with under four births (17) . Some case control studies have shown the association with parity for cervix carcinoma (18) . Th e eff ect of parity in cervical cancer development seems to be mainly detectable in countries with high fertility rates and is rarely found in lowparity countries. Parity is probably a good marker of the oestrogen-hormonal environment throughout the fertile years of a woman as well as a marker of repeated cervical trauma among highly parous women. It is not known whether hormones intervene in cervical carcinogenesis but oestradiol has been reported to induce immortalization of HPV-infected cells (19) . According to a study, high parity was associated with HPV infection but not with the risk of carcinoma of cervix (20) . Comparing the cervical lesion group and the control group, our study indicated that the number of births did not have a role in the development of any cervical lesions. However, in the cervical lesion group, the mean number of parities in the patients who had ≥4 births was higher than the patients who had <4 births. According to our study, the prospect of having a lesion in the cervix increases if a patient has 4 or more births.
Even though the present study has limitations and further prospective studies are needed, this could represent an initial attempt to refl ect the prevalence and the distribution of cervical lesions in the eastern regions in Turkey.
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marriage and fi rst sexual intercourse, which are lower in eastern regions of Turkey, and the habit of getting fellow wives, which is still widely accepted in the rural population of the eastern and southeastern regions of Turkey, we can say that the socioeconomic status and the awareness of cervical health in women are lower than the other regions.
Th e prevalence of ASC-US, L-SIL, H-SIL, and AGC in the USA has been reported as 3.9%, 2.1%, 0.5%, and 0.2%, respectively (10) . In the present study the overall prevalence of cytological abnormality was 6.21% and the prevalence of ASC-US, L-SIL, H-SIL, and AGC was 5.53%, 0.60%, 0.24%, and 0.30%, respectively. It is well known that the prevalence of preinvasive and invasive abnormal cervical cytology varies according to patient population, diagnostic criteria utilized, and the experience and skill of the cytologist and pathologist. Th e prevalence of abnormal cervical cytology in the present study was diff erent from and approximately 4 times higher (1.8%) than in those previously reported from the western regions of Turkey (3). In another study from the Şanlıurfa province, which is in the southeast region and the worst city of Turkey in socioeconomic conditions according to the State Institute of Statistics, 9,079 smears were taken and ASC-US was detected in 1.6% of the cases, ASC-H in 0.06% of the cases, L-SIL in 0.07% of the cases, H-SIL in 0.02% of the cases, AGC in 0.05% of the cases, and SCC in only in one patient which was determined to be 0.01% (8) .
Genital HPV infection is the most common sexually transmitted viral infection worldwide. It is associated with various clinical conditions, ranging from asymptomatic infections to benign and malignant diseases, which include genital warts, cervical intraepithelial neoplasia and invasive cervical cancer (11) . It has been clearly demonstrated with planned follow-up of L-SIL cases that these precancerous lesions persist longer and progress more quickly in women with oncogenic HPV infection than in women with nononcogenic infection or no HPV infection (12) .
In a study from Gaziantep province, which is one of the biggest cities in the southeast region of Turkey, the prevalence and genotype distribution were studied. HPV DNA was positive in 16.9% of the women overall and in 15.1% of women with normal cervical cytology as the rates in newer studies from Turkey (13, 14) . Th e most common genotypes in HPV infected women were HPV 18 and HPV 16, which are also the most commonly detected types worldwide. Other common types were HPV 54, 6, 58 and 59 among the female population in Gaziantep province. According to that study, there was a signifi cant association
